Skip to main content
 

AHA Innovators’ Network Member AliveCor receives unique Dual FDA clearance of AI that can detect life-threatening cardiac conditions

AHA Innovators’ Network Member AliveCor receives unique Dual FDA clearance of AI that can detect life-threatening cardiac conditions

AHA Innovators’ Network Member Company was granted an unique dual clearance from the FDA for the AI detection of
life-threatening cardiac conditions, including heart attacks.

Learn more here.

More News

  • Innovators’ Network Member Cleerly Closes New Round of Funding

  • AHA Innovators’ Network Member Accurkardia receives FDA Breakthrough Device Designation on New Condition Area

  • Alumni AHA Innovators’ Network Member Companies iRhythm and BioIntelliSense Enter Agreement